4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-13-007044
Director bought 300,042 shares at an average $3.51 ($1,052,148)
From the SEC's structured data for this filing
Trades in this filing
BRADSHER NEAL C · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-12-26 | Purchase : show line 1 in the form | +69,042 | $3.53 | $243,718 | 9,091,262 | D |
| 2013-12-26 | Purchase : show line 2 in the form | +0 | 9,091,262 | I | ||
| 2013-12-27 | Purchase : show line 3 in the form | +56,000 | $3.53 | $197,680 | 9,147,262 | D |
| 2013-12-27 | Purchase : show line 4 in the form | +0 | 9,147,262 | I | ||
| 2013-12-30 | Purchase : show line 5 in the form | +175,000 | $3.49 | $610,750 | 9,322,262 | D |
| 2013-12-30 | Purchase : show line 6 in the form | +0 | 9,322,262 | I | ||
| Open-market purchases · 300,042 sh · avg $3.51 · $1,052,148 | ||||||
Loading xslF345X03/p1441379.xml…